Pelthos Therapeutics (PTHS) Cash from Investing Activities (2025 - 2026)

Pelthos Therapeutics (PTHS) posted quarterly Cash from Investing Activities of -$8.0 million for Q4 2025.

Pelthos Therapeutics (PTHS) Cash from Investing Activities (2025 - 2026) Analysis & Trends

Pelthos Therapeutics' Cash from Investing Activities history runs 1 years deep, the most recent figure standing at -$8.0 million for Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Investing Activities (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-45.80 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-92.70 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	329.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-49.35 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-363.46 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-3.17 Bn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	24.51 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-229.72 Mn
10	Pelthos Therapeutics	91.09 Mn	66.53 Mn	21.23 Mn	-196,000.00

Download Data